Free Trial

Kiromic BioPharma (KRBP) Stock Price, News & Analysis

+0.13 (+4.19%)
(As of 05/21/2024 ET)
Today's Range
50-Day Range
52-Week Range
4,548 shs
Average Volume
7,117 shs
Market Capitalization
$4.97 million
P/E Ratio
Dividend Yield
Price Target
KRBP stock logo

About Kiromic BioPharma Stock (NASDAQ:KRBP)

Kiromic BioPharma, Inc., a clinical stage biotherapeutics company, utilizes engineered and non-engineered Gamma Delta T cell (GDT) technologies to develop therapies for solid tumors. The company develops Deltacel-01, which is in Phase 1 clinical trial, for patients with non-small cell lung cancer; Isocel in combination with low-dose radiation to treat Mesothelin Isoform 2 positive solid malignancies; ALEXIS-ISO-1, an allogeneic GDT therapy product that targets an isoform of mesothelin; Procel in combination with low-dose radiation to treat PD-L1 positive solid malignancies; and ALEXIS-PRO-1, an allogeneic GDT therapy product that targets PD-L1. It has a license agreement with Longwood University; and a research and development collaboration agreement with Molipharma, S.R.L. The company was formerly known as Kiromic, Inc. and changed its name to Kiromic BioPharma, Inc. in December 2019. Kiromic BioPharma, Inc. was founded in 2006 and is headquartered in Houston, Texas.

KRBP Stock Price History

KRBP Stock News Headlines

Kiromic BioPharma (NASDAQ:KRBP) Trading 3.4% Higher
Kiromic BioPharma Announces Uplisting to OTCQB Market
Kiromic BioPharma Inc Ordinary Shares
Staidson Beijing Biopharma (300204)
See More Headlines
Receive KRBP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kiromic BioPharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Fiscal Year End

Industry, Sector and Symbol

Biological products, except diagnostic
Current Symbol
Year Founded


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
Book Value
($7.25) per share


Free Float
Market Cap
$4.97 million
Not Optionable
5G Stocks: The Path Forward is Profitable Cover

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Key Executives

  • Mr. Pietro Bersani CPA (Age 56)
    J.D., CEO & Director
    Comp: $891.69k
  • Mr. Brian Hungerford (Age 48)
    Chief Financial Officer
    Comp: $160.69k
  • Dr. Leonardo Mirandola Ph.D. (Age 42)
    Chief Scientific Officer & Interim COO
    Comp: $383.32k
  • Dr. Scott Dahlbeck M.D. (Age 62)
    Pharm.D., PharmD, Chief of Staff
    Comp: $359.08k

KRBP Stock Analysis - Frequently Asked Questions

How have KRBP shares performed in 2024?

Kiromic BioPharma's stock was trading at $0.87 on January 1st, 2024. Since then, KRBP stock has increased by 271.3% and is now trading at $3.23.
View the best growth stocks for 2024 here

How were Kiromic BioPharma's earnings last quarter?

Kiromic BioPharma, Inc. (NASDAQ:KRBP) announced its quarterly earnings data on Friday, May, 10th. The company reported ($1.00) earnings per share for the quarter.

When did Kiromic BioPharma's stock split?

Shares of Kiromic BioPharma reverse split on the morning of Monday, March 13th 2023. The 1-30 reverse split was announced on Monday, March 13th 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, March 13th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

When did Kiromic BioPharma IPO?

Kiromic BioPharma (KRBP) raised $16 million in an initial public offering (IPO) on Friday, October 16th 2020. The company issued 1,200,000 shares at a price of $12.00-$14.00 per share. ThinkEquity (a division of Fordham Financial Management) acted as the underwriter for the IPO and Paulson Investment Company was co-manager.

How do I buy shares of Kiromic BioPharma?

Shares of KRBP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KRBP) was last updated on 5/21/2024 by Staff

From Our Partners